优化再生医学原理以对抗新冠肺炎的一步

Annals of the National Academy of Medical Sciences India Pub Date : 2021-06-21 DOI:10.1055/s-0041-1731597

Shilpa Sharma, Madhan Jeyaraman, S. Muthu, T. Anudeep, Naveen Jeyaraman, A. S. Shringeri, Vinodh Kumar, Rajeswari Somasundaram, R. Jain, S. Jha

{"title":"优化再生医学原理以对抗新冠肺炎的一步","authors":"Shilpa Sharma, Madhan Jeyaraman, S. Muthu, T. Anudeep, Naveen Jeyaraman, A. S. Shringeri, Vinodh Kumar, Rajeswari Somasundaram, R. Jain, S. Jha","doi":"10.1055/s-0041-1731597","DOIUrl":null,"url":null,"abstract":"Abstract Drugs are currently not licensed in specific to pulverize COVID-19. On an emergency basis, vaccines were approved to prevent the further spread of COVID-19. This serves as a potential background for considering the optimization of biologics. In this context, evidence on convalescent plasma and stem cells has shown a beneficial role. Here, we have considered this as plausible therapy, and further hypothesize that their cocktails will synergistically boost the immunogenicity to relegate COVID-19. This warrants a large volume clinical trial on an emergent basis, because the sooner we establish a safe and effective cure, the better.","PeriodicalId":53332,"journal":{"name":"Annals of the National Academy of Medical Sciences India","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0041-1731597","citationCount":"0","resultStr":"{\"title\":\"A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19\",\"authors\":\"Shilpa Sharma, Madhan Jeyaraman, S. Muthu, T. Anudeep, Naveen Jeyaraman, A. S. Shringeri, Vinodh Kumar, Rajeswari Somasundaram, R. Jain, S. Jha\",\"doi\":\"10.1055/s-0041-1731597\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Drugs are currently not licensed in specific to pulverize COVID-19. On an emergency basis, vaccines were approved to prevent the further spread of COVID-19. This serves as a potential background for considering the optimization of biologics. In this context, evidence on convalescent plasma and stem cells has shown a beneficial role. Here, we have considered this as plausible therapy, and further hypothesize that their cocktails will synergistically boost the immunogenicity to relegate COVID-19. This warrants a large volume clinical trial on an emergent basis, because the sooner we establish a safe and effective cure, the better.\",\"PeriodicalId\":53332,\"journal\":{\"name\":\"Annals of the National Academy of Medical Sciences India\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1055/s-0041-1731597\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of the National Academy of Medical Sciences India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0041-1731597\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the National Academy of Medical Sciences India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0041-1731597","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

摘要药物目前尚未获得专门用于粉碎新冠肺炎的许可。在紧急情况下，批准了防止新冠肺炎进一步传播的疫苗。这是考虑生物制剂优化的潜在背景。在这种情况下，关于恢复期血浆和干细胞的证据显示了有益的作用。在这里，我们认为这是一种可行的治疗方法，并进一步假设他们的鸡尾酒将协同提高免疫原性，从而使新冠肺炎降级。这就需要在紧急情况下进行大规模的临床试验，因为我们越早建立安全有效的治疗方法越好。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19

Abstract Drugs are currently not licensed in specific to pulverize COVID-19. On an emergency basis, vaccines were approved to prevent the further spread of COVID-19. This serves as a potential background for considering the optimization of biologics. In this context, evidence on convalescent plasma and stem cells has shown a beneficial role. Here, we have considered this as plausible therapy, and further hypothesize that their cocktails will synergistically boost the immunogenicity to relegate COVID-19. This warrants a large volume clinical trial on an emergent basis, because the sooner we establish a safe and effective cure, the better.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of the National Academy of Medical Sciences India

自引率

0.00%

发文量

审稿时长

12 weeks